1zj7
From Proteopedia
(Difference between revisions)
| Line 1: | Line 1: | ||
| - | {{Seed}} | ||
[[Image:1zj7.png|left|200px]] | [[Image:1zj7.png|left|200px]] | ||
| Line 20: | Line 19: | ||
==About this Structure== | ==About this Structure== | ||
| - | + | [[1zj7]] is a 1 chain structure of [[Virus protease]] with sequence from [http://en.wikipedia.org/wiki/Human_immunodeficiency_virus_1 Human immunodeficiency virus 1]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1ZJ7 OCA]. | |
| + | |||
| + | ==See Also== | ||
| + | *[[Virus protease]] | ||
==Reference== | ==Reference== | ||
| - | <ref group="xtra">PMID: | + | <ref group="xtra">PMID:016970402</ref><references group="xtra"/> |
[[Category: HIV-1 retropepsin]] | [[Category: HIV-1 retropepsin]] | ||
| - | [[Category: Human immunodeficiency virus]] | + | [[Category: Human immunodeficiency virus 1]] |
[[Category: Dohnalek, J.]] | [[Category: Dohnalek, J.]] | ||
[[Category: Duskova, J.]] | [[Category: Duskova, J.]] | ||
| Line 32: | Line 34: | ||
[[Category: Skalova, T.]] | [[Category: Skalova, T.]] | ||
[[Category: Hiv]] | [[Category: Hiv]] | ||
| - | [[Category: | + | [[Category: Hydrolase-hydrolase inhibitor complex]] |
| - | [[Category: Peptidomimetic]] | + | [[Category: Peptidomimetic inhibitor]] |
[[Category: Protease]] | [[Category: Protease]] | ||
| - | |||
| - | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Tue Feb 17 09:10:08 2009'' | ||
Revision as of 11:36, 16 November 2011
Contents |
Crystal structure of a complex of mutant HIV-1 protease (A71V, V82T, I84V) with a hydroxyethylamine peptidomimetic inhibitor BOC-PHE-PSI[S-CH(OH)CH2NH]-PHE-GLU-PHE-NH2
Template:ABSTRACT PUBMED 16970402
About this Structure
1zj7 is a 1 chain structure of Virus protease with sequence from Human immunodeficiency virus 1. Full crystallographic information is available from OCA.
See Also
Reference
- Skalova T, Dohnalek J, Duskova J, Petrokova H, Hradilek M, Soucek M, Konvalinka J, Hasek J. HIV-1 protease mutations and inhibitor modifications monitored on a series of complexes. Structural basis for the effect of the A71V mutation on the active site. J Med Chem. 2006 Sep 21;49(19):5777-84. PMID:16970402 doi:10.1021/jm0605583
